Stockreport

Sagimet Biosciences Shares Jump 30% on Acne Trial Expansion Plans [Yahoo! Finance]

Sagimet Biosciences Inc.  (SGMT) 
PDF clinical trial of denifanstat for moderate to severe acne in the U.S. during the second half of 2026. The clinical-stage biopharmaceutical company said it is advancing [Read more]